SCHEMBL24754238

SCHEMBL24754238

CN(C)C(=O)c1ccc(Cn2ncc3ccccc3c2=O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.59
KMT2A Q03164 2/20 0.48
PLA2G10 O15496 1/20 0.44
GAA P10253 1/20 0.44
NPC1 O15118 1/20 0.43
MITF O75030 1/20 0.43
PKM P14618 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 4/20 0.42
HPGD P15428 3/20 0.42
POLB P06746 2/20 0.42
APOBEC3G Q9HC16 1/20 0.42
MAPT P10636 1/20 0.42
LMNA P02545 1/20 0.42
NPSR1 Q6W5P4 1/20 0.41
DRD2 P14416 1/20 0.41
TBXA2R P21731 1/20 0.41
NCOA1 Q15788 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9027681 0.80 TDP1 (0.72) TDP1KMT2AGAANPC1MITF
SCHEMBL29703247 0.80 TDP1 (0.72) TDP1KMT2AGAANPC1MITF
Hydrochloric Acid SCHEMBL30088832 0.79 TDP1 (0.70) TDP1KMT2AGAANPC1MITF
SCHEMBL24754241 0.78 LMNA (0.67) TDP1KMT2AGAASMN1; SMN2ALDH1A1
SCHEMBL29703239 0.78 TDP1 (0.69) TDP1NPC1MITFPKMRAB9A
SCHEMBL7894526 0.78 TDP1 (0.69) TDP1NPC1MITFPKMRAB9A
SCHEMBL30579886 0.77 TDP1 (0.64) TDP1NPC1MITFPKMRAB9A
SCHEMBL28244751 0.74 TDP1 (0.60) TDP1KMT2APLA2G10GAANPC1
SCHEMBL24754239 0.73 KMT2A (0.42) KMT2AGAASMN1; SMN2ALDH1A1HPGD
SCHEMBL24754234 0.72 CYP1A2 (0.40) TDP1KMT2ASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022263829-A1 COMPOUNDS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY Z Factor Limited (GB) 2022-12-22 WO disclosed